跳至主要内容
临床试验/NCT03297021
NCT03297021已完成4 期

Effects of Ondansetron Dose and Timing on Rates of Post-operative Nausea and Vomiting

Icahn School of Medicine at Mount Sinai1 个研究点 分布在 1 个国家目标入组 141 人开始时间: 2017年10月23日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
141
试验地点
1
主要终点
Nausea Scale

研究概览

简要总结

The aim is to evaluate the effectiveness of three different regimens of prophylactic ondansetron on the incidence and severity of post-operative nausea and vomiting.

详细描述

Patients will be randomize to one of three arms: 4mg ondansetron pre-emergence, 8 mg ondansetron pre-emergence, or 4mg ondansetron pre-incision followed by 4mg ondansetron pre-emergence. Primary outcome will be incidence of PONV in the PACU prior to discharge.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Factorial
主要目的
Prevention
盲法
Triple (Participant, Care Provider, Outcomes Assessor)

盲法说明

Random allocation by opaque envelope and random number generator. Investigator will draw up study medication and give to care-providers. Outcome assessor not present for drawing up of medications.

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • ASA I, II, III presenting for ambulatory surgery to be performed under general anesthesia

排除标准

  • Patients with allergies or contraindications to study medications

研究组 & 干预措施

Ondansetron 4mg Pre-emergence

Placebo Comparator

干预措施: Ondansetron 4 MG (Drug)

Ondansetron 8mg Pre-emergence

Experimental

干预措施: Ondansetron 8mg (Drug)

Ondansetron Pre-Incision and Pre-emergence

Experimental

4mg Ondansetron Pre-Incision and 4mg Ondansetron Pre-emergence

干预措施: Ondansetron 4 MG (Drug)

结局指标

主要结局

Nausea Scale

时间窗: average of 4 hours in PACU and POD1

Nausea Scale - full scale from 1-10, with higher score indicating more symptom of nausea

次要结局

  • Number of Participants Who Needed Rescue Anti-emetics(average of 4 hours)
  • Number of Participants With Episodes of Vomiting in the PACU(average of 4 hours)
  • Number of Participants With Symptoms on POD 1(Day 1)
  • Total Anesthesia Time(intraoperative, up to 3.5 hours)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Daniel Katz

Assistant Professor

Icahn School of Medicine at Mount Sinai

研究点 (1)

Loading locations...

相似试验